The TMPRSS2-ERG fusion gene, comprising the androgen-responsive genes transmembrane protease, serine 2 (TMPRSS2), and estrogen-regulated gene (ERG), was observed in ~40–80 % of prostate cancers in 2005 [20]. The gene discussed is TMPRSS2; the disease is Familial prostate cancer.